Androgen-regulated genes affected by L-dopa decarboxylase in prostate cancer
Author Information
Author(s): Katia Margiotti, Wafa Latif, Helen Cheng, Giuseppe Novelli, Colleen C. Nelson, Paul S. Rennie
Primary Institution: University of British Columbia
Hypothesis
How does L-dopa decarboxylase (DDC) influence androgen receptor signaling in prostate cancer cells?
Conclusion
The study shows that DDC overexpression in prostate cancer cells alters the expression of several androgen-regulated genes, which may contribute to cancer progression.
Supporting Evidence
- DDC is identified as a coactivator of the androgen receptor.
- 35 genes were found to be differentially expressed due to DDC overexpression.
- The study confirmed gene expression changes using quantitative real-time RT-PCR.
Takeaway
This study found that a protein called DDC can change how prostate cancer cells respond to hormones, which might help the cancer grow.
Methodology
The study used tetracycline-inducible LNCaP-DDC prostate cancer cells and oligonucleotide microarray analysis to identify DDC downstream target genes.
Statistical Information
P-Value
p ≤ 0.05
Statistical Significance
p ≤ 0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website